Found 5 matching trials
Study to Evaluate the Safety and Efficacy of Selonsertib, Firsocostat, Cilofexor, and Combinations in Participants With Bridging Fibrosis or Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) PHASE2 The primary objectives of this study are:
* To assess the safety and toler...
Show More Location
The Institute for Liver Health
Learn More & Join Trial
Study of Cilofexor in Adults With Primary Sclerosing Cholangitis PHASE3 The primary objective of this study is to evaluate whether cilofexor reduce...
Show More Location
Institute For Liver Health
Learn More & Join Trial
Study of Semaglutide, and Cilofexor/Firsocostat, Alone and in Combination, in Adults With Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) PHASE2 The goal of this clinical study is to understand whether the study drugs, s...
Show More Location
University of Alabama at Birmingham Hospital
Learn More & Join Trial
Study to Evaluate the Safety, Tolerability, and Efficacy of Cilofexor in Adults With Primary Sclerosing Cholangitis Without Cirrhosis PHASE2 The primary objective of this study is to evaluate the safety and tolerabil...
Show More Location
University of California, Davis Medical Center
Learn More & Join Trial
Study to Evaluate the Safety, Tolerability, and Efficacy of Cilofexor in Adults With Primary Biliary Cholangitis Without Cirrhosis PHASE2 The primary objective of this study is to evaluate the safety and tolerabil...
Show More Location
Multiple Locations
Learn More & Join Trial